obeticholic acid Ocaliva
Selected indexed studies
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. (Lancet, 2019) [PMID:31813633]
- Obeticholic Acid. (, 2012) [PMID:31644113]
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. (N Engl J Med, 2016) [PMID:27532829]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Obeticholic Acid. (2012) pubmed
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. (2019) pubmed
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. (2016) pubmed
- FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid. (2024) pubmed
- Obeticholic Acid. (2026) pubmed
- COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls. (2025) pubmed
- Primary biliary cholangitis: Personalizing second-line therapies. (2025) pubmed
- Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Therapy Landscape. (2025) pubmed
- Primary biliary cholangitis. (2024) pubmed
- Nonalcoholic fatty liver disease: another leap forward. (2021) pubmed